2019-03-06Ascelia Pharma’s new share issue in connection with the IPO on Nasdaq Stockholm was significantly oversubscribedRead more
2019-02-20Ascelia Pharma publishes prospectus in connection with Initial Public Offering on Nasdaq StockholmRead more
2018-11-19Ascelia Pharma receives positive feedback from FDA on design of the pivotal Phase 3 study with Mangoral®Read more
2018-11-13Encouraging results from clinical Phase I study of Oncoral presented in a new publicationRead more
2018-05-16Ascelia Pharma has raised SEK 60 million to finalize phase III preparations for Mangoral®Read more
